2024-09-012025-08-312025-08-31false13571317VITABEL NUTRITION LTD2026-07-1310612falseiso4217:GBPxbrli:pure135713172024-08-31135713172025-08-31135713172024-09-012025-08-31135713172023-08-31135713172024-08-31135713172023-09-012024-08-3113571317bus:SmallEntities2024-09-012025-08-3113571317bus:AuditExempt-NoAccountantsReport2024-09-012025-08-3113571317bus:FullAccounts2024-09-012025-08-3113571317bus:PrivateLimitedCompanyLtd2024-09-012025-08-3113571317core:WithinOneYear2025-08-3113571317core:AfterOneYear2025-08-3113571317core:WithinOneYear2024-08-3113571317core:AfterOneYear2024-08-3113571317core:ShareCapital2025-08-3113571317core:SharePremium2025-08-3113571317core:RevaluationReserve2025-08-3113571317core:OtherReservesSubtotal2025-08-3113571317core:RetainedEarningsAccumulatedLosses2025-08-3113571317core:ShareCapital2024-08-3113571317core:SharePremium2024-08-3113571317core:RevaluationReserve2024-08-3113571317core:OtherReservesSubtotal2024-08-3113571317core:RetainedEarningsAccumulatedLosses2024-08-3113571317core:LandBuildings2025-08-3113571317core:PlantMachinery2025-08-3113571317core:Vehicles2025-08-3113571317core:FurnitureFittings2025-08-3113571317core:OfficeEquipment2025-08-3113571317core:NetGoodwill2025-08-3113571317core:IntangibleAssetsOtherThanGoodwill2025-08-3113571317core:ListedExchangeTraded2025-08-3113571317core:UnlistedNon-exchangeTraded2025-08-3113571317core:LandBuildings2024-08-3113571317core:PlantMachinery2024-08-3113571317core:Vehicles2024-08-3113571317core:FurnitureFittings2024-08-3113571317core:OfficeEquipment2024-08-3113571317core:NetGoodwill2024-08-3113571317core:IntangibleAssetsOtherThanGoodwill2024-08-3113571317core:ListedExchangeTraded2024-08-3113571317core:UnlistedNon-exchangeTraded2024-08-3113571317core:LandBuildings2024-09-012025-08-3113571317core:PlantMachinery2024-09-012025-08-3113571317core:Vehicles2024-09-012025-08-3113571317core:FurnitureFittings2024-09-012025-08-3113571317core:OfficeEquipment2024-09-012025-08-3113571317core:NetGoodwill2024-09-012025-08-3113571317core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3113571317core:ListedExchangeTraded2024-09-012025-08-3113571317core:UnlistedNon-exchangeTraded2024-09-012025-08-3113571317core:MoreThanFiveYears2024-09-012025-08-3113571317core:Non-currentFinancialInstruments2025-08-3113571317core:Non-currentFinancialInstruments2024-08-3113571317dpl:CostSales2024-09-012025-08-3113571317dpl:DistributionCosts2024-09-012025-08-3113571317core:LandBuildings2024-09-012025-08-3113571317core:PlantMachinery2024-09-012025-08-3113571317core:Vehicles2024-09-012025-08-3113571317core:FurnitureFittings2024-09-012025-08-3113571317core:OfficeEquipment2024-09-012025-08-3113571317dpl:AdministrativeExpenses2024-09-012025-08-3113571317core:NetGoodwill2024-09-012025-08-3113571317core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3113571317dpl:GroupUndertakings2024-09-012025-08-3113571317dpl:ParticipatingInterests2024-09-012025-08-3113571317dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-3113571317core:ListedExchangeTraded2024-09-012025-08-3113571317dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-3113571317core:UnlistedNon-exchangeTraded2024-09-012025-08-3113571317dpl:CostSales2023-09-012024-08-3113571317dpl:DistributionCosts2023-09-012024-08-3113571317core:LandBuildings2023-09-012024-08-3113571317core:PlantMachinery2023-09-012024-08-3113571317core:Vehicles2023-09-012024-08-3113571317core:FurnitureFittings2023-09-012024-08-3113571317core:OfficeEquipment2023-09-012024-08-3113571317dpl:AdministrativeExpenses2023-09-012024-08-3113571317core:NetGoodwill2023-09-012024-08-3113571317core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3113571317dpl:GroupUndertakings2023-09-012024-08-3113571317dpl:ParticipatingInterests2023-09-012024-08-3113571317dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3113571317core:ListedExchangeTraded2023-09-012024-08-3113571317dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3113571317core:UnlistedNon-exchangeTraded2023-09-012024-08-3113571317core:NetGoodwill2025-08-3113571317core:IntangibleAssetsOtherThanGoodwill2025-08-3113571317core:LandBuildings2025-08-3113571317core:PlantMachinery2025-08-3113571317core:Vehicles2025-08-3113571317core:FurnitureFittings2025-08-3113571317core:OfficeEquipment2025-08-3113571317core:AfterOneYear2025-08-3113571317core:WithinOneYear2025-08-3113571317core:ListedExchangeTraded2025-08-3113571317core:UnlistedNon-exchangeTraded2025-08-3113571317core:ShareCapital2025-08-3113571317core:SharePremium2025-08-3113571317core:RevaluationReserve2025-08-3113571317core:OtherReservesSubtotal2025-08-3113571317core:RetainedEarningsAccumulatedLosses2025-08-3113571317core:NetGoodwill2024-08-3113571317core:IntangibleAssetsOtherThanGoodwill2024-08-3113571317core:LandBuildings2024-08-3113571317core:PlantMachinery2024-08-3113571317core:Vehicles2024-08-3113571317core:FurnitureFittings2024-08-3113571317core:OfficeEquipment2024-08-3113571317core:AfterOneYear2024-08-3113571317core:WithinOneYear2024-08-3113571317core:ListedExchangeTraded2024-08-3113571317core:UnlistedNon-exchangeTraded2024-08-3113571317core:ShareCapital2024-08-3113571317core:SharePremium2024-08-3113571317core:RevaluationReserve2024-08-3113571317core:OtherReservesSubtotal2024-08-3113571317core:RetainedEarningsAccumulatedLosses2024-08-3113571317core:NetGoodwill2023-08-3113571317core:IntangibleAssetsOtherThanGoodwill2023-08-3113571317core:LandBuildings2023-08-3113571317core:PlantMachinery2023-08-3113571317core:Vehicles2023-08-3113571317core:FurnitureFittings2023-08-3113571317core:OfficeEquipment2023-08-3113571317core:AfterOneYear2023-08-3113571317core:WithinOneYear2023-08-3113571317core:ListedExchangeTraded2023-08-3113571317core:UnlistedNon-exchangeTraded2023-08-3113571317core:ShareCapital2023-08-3113571317core:SharePremium2023-08-3113571317core:RevaluationReserve2023-08-3113571317core:OtherReservesSubtotal2023-08-3113571317core:RetainedEarningsAccumulatedLosses2023-08-3113571317core:AfterOneYear2024-09-012025-08-3113571317core:WithinOneYear2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3113571317core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3113571317core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3113571317core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3113571317core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3113571317core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3113571317core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3113571317core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3113571317core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3113571317core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3113571317core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3113571317core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3113571317core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3113571317core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3113571317core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3113571317core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3113571317bus:Director12024-09-012025-08-31

VITABEL NUTRITION LTD

Registered Number
13571317
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

VITABEL NUTRITION LTD
Company Information
for the year from 1 September 2024 to 31 August 2025

Director

A A Steiner

Company Secretary

A A Steiner

Registered Address

27 Old Gloucester Street
London
WC1N 3AX

Registered Number

13571317 (England and Wales)
VITABEL NUTRITION LTD
Balance Sheet as at
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets34141,007
Investments422,10922,109
22,52323,116
Current assets
Debtors519,19514,741
Cash at bank and on hand10,44439,300
29,63954,041
Creditors amounts falling due within one year6(14,117)(28,968)
Net current assets (liabilities)15,52225,073
Total assets less current liabilities38,04548,189
Net assets38,04548,189
Capital and reserves
Called up share capital143143
Share premium99,95799,957
Profit and loss account(62,055)(51,911)
Shareholders' funds38,04548,189
The financial statements were approved and authorised for issue by the Director on 13 July 2026, and are signed on its behalf by:
A A Steiner
Director
Registered Company No. 13571317
VITABEL NUTRITION LTD
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered office address is 27 Old Gloucester Street, London, WC1N 3AX.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland", including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The Financial statements have been prepared under the historical cost convention. The accounting policies set out below have, unless otherwise stated, been applied consistently to the period presented in the financial statements.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
Going concern
The director has a reasonable expectation that the company will continue to have adequate resources to remain in operational existence for the foreseeable future and also for a period of more than one year from the date of approval of these accounts. In addition to this, continued support will be available from the shareholders for the foreseeable future. Therefore, the going concern assumption has been applied in preparing these financial statements.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on the straight-line basis at the following rate to write off each asset over its estimated useful life. Computer Equipment - 33%
Investments
Fixed assets investments relate to the company's holdings in its subsidiary. Subsidiary is an entity in which Vitabel Nutrition Ltd holds more than half of the voting rights or has the ability to direct the financial and reporting principles followed
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand and call deposits.
Financial instruments
All of the financial instruments of the company are basic and the company has elected to apply the provisions of Section 11 "Basic Financial Instruments of FRS 10” to all its financial instruments. Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instruments. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Equity instruments Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company
2.Average number of employees
There were no staff costs for the year ended 31 August 2025 nor for the period ended 31 August 2024.

20252024
Average number of employees during the year00
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 September 241,7991,799
At 31 August 251,7991,799
Depreciation and impairment
At 01 September 24792792
Charge for year593593
At 31 August 251,3851,385
Net book value
At 31 August 25414414
At 31 August 241,0071,007
4.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 September 2422,10922,109
At 31 August 2522,10922,109
Net book value
At 31 August 2522,10922,109
At 31 August 2422,10922,109

Notes

1Investments in group undertakings and participating interests
5.Debtors: amounts due within one year

2025

2024

££
Amounts owed by group undertakings5,543-
Other debtors13,65214,741
Total19,19514,741
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables1,2543,166
Taxation and social security-12,727
Other creditors12,86313,075
Total14,11728,968
7.Related party transactions
The company has taken advantage of the exemption under FRS 102 Paragraph 33.1A from disclosing transactions with other wholly-owned members of the group.
8.Controlling party
The ultimate controlling party is the director Mrs Anabel Alessandra Steiner.